BRIEF-Vexim says Anvisa approves Spinejack implants in Brazil
* HAS RECEIVED REGULATORY APPROVAL FROM ANVISA(1), BRAZIL'S NATIONAL HEALTH SURVEILLANCE AGENCY, IN ORDER TO COMMERCIALIZE SPINEJACK® IN BRAZIL.
May 19 U.S.FDA
* Abbott Vascular recalls in U.S. 132,040 devices of coronary catheters due to risks stemming from difficulty removing balloon sheath
* Abbott initiated voluntary recall of specific lots of 3 catheters due to 19 reports of injury, and 1 report of death Source text : [ID:bit.ly/2qC1YLZ]
SAO PAULO, May 29 Brazilian healthcare services provider Notre Dame Intermédica Sistema de Saúde SA on Monday filed for regulatory clearance to launch an initial public offering, the latest in a wave of stock listings in Latin America's largest economy after a years-long drought.